California Pacific Medical Center
13
1
1
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 13 trials
100.0%
+13.5% vs industry average
38%
5 trials in Phase 3/4
25%
2 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)
Role: collaborator
The PERFusion Use in Stroke Evaluation Study
Role: collaborator
Immunosuppression Management in Renal Transplant Recipients With Transplant Excellence Based on TruGraf Test
Role: collaborator
Yttrium90, Ipilimumab, & Nivolumab for Uveal Melanoma With Liver Metastases
Role: collaborator
Does Atrial Fibrillation (AF) Termination Without Additional Ablation Influence Outcome?
Role: collaborator
PV Reconnection After PVAI at Different Power Settings and Adenosine Provocation
Role: collaborator
Evaluation of Intraoperative Usage of Sentinella in Detecting Sentinel Lymph Nodes
Role: collaborator
Lucentis in Advanced Macular Degeneration
Role: collaborator
Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation
Role: collaborator
Nitrates and Bone Turnover; Nitrates and Bone Turnover Bisphosphonate Sub-Study
Role: collaborator
Ablation of Clinical Ventricular Tachycardia Versus Addition of Substrate Ablation on the Long Term Success Rate of VT Ablation
Role: collaborator
Effect of Amiodarone on the Procedure Outcome in Long-standing Persistent Atrial Fibrillation Undergoing Pulmonary Vein Antral Isolation
Role: collaborator
Advancing Telestroke Care: A Prospective Observational Study
Role: collaborator
All 13 trials loaded